Min-Jui Richard Shen

Patent owner in reexamination·3 ex parte reexams

Min-Jui Richard Shen's patents have been the subject of 3 USPTO ex parte reexaminations. Its patents are most often challenged by Roche Molecular Systems, Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.

Filings by year

2
15
1
16

Outcome track record

How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.

  • Certificate outcome split across every bucket
  • Claim-survival rate

Defense metrics

Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.

  • Survival rate of closed proceedings
  • Average pendency in months

Challengers & examiners

Which requesters most often challenge this owner's patents, and which examiners decide them.

  • Top requesters
  • Most frequent examiners

Recent reexaminations (3)

Control #FiledPatentTitleRequesterStatus
90/013,671Jan 4, 20167,955,794MULTIPLEX NUCLEIC ACID REACTIONS—Closed
90/013,667Dec 29, 20157,955,794MULTIPLEX NUCLEIC ACID REACTIONS—Closed
90/013,666Dec 21, 20157,955,794MULTIPLEX NUCLEIC ACID REACTIONSRoche Molecular Systems, Inc.Closed

See the full reexam picture for Min-Jui Richard Shen

Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.